Augmedix, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
AUGX on Nasdaq
Location
111 Sutter Street, Suite 1300, San Francisco, CA

Insiders trading volume in the past year

Augmedix, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RedCo II Master Fund, L.P. Director, 10%+ Owner $42.2M May 2, 2023
RedCo I, L.P. Director, 10%+ Owner $24.3M Oct 5, 2020
Redmile Private Investments II, L.P. Director, 10%+ Owner $22.3M Oct 5, 2020
Dcm Vi, L.P. Director, 10%+ Owner $20.2M Oct 28, 2021
Jennifer M. Carter Director, 10%+ Owner $19.5M Oct 28, 2021
McKesson Ventures, LLC Former 10% Owner $7.63M Dec 13, 2022
Joseph Marks Director $255K Jun 16, 2023
Saurav Chatterjee Chief Technology Officer $0 -$2.1K -100% Oct 2, 2024
Ian Shakil CHIEF STRATEGY OFFICER, Director $0 -$1.9M -100% Oct 2, 2024
Sandra Breber Chief Operating Officer $0 -$2.8K -100% Oct 2, 2024
Jonathan Hawkins Chief Revenue Officer $0 -$2.1K -100% Oct 2, 2024
Robert C. Faulkner Director $0 Oct 2, 2024
Redmile Group, LLC Director, 10%+ Owner $0 Oct 2, 2024
Tomer Levy Svp, Engineering $0 Oct 2, 2024
Emmanuel Krakaris PRESIDENT, CEO, AND SECRETARY, Director $0 -$4.2K -100% Oct 2, 2024
William J. Febbo Director $0 Oct 2, 2024
Roderick H. O'Reilly Director $0 Oct 2, 2024
Jason Krikorian Director $0 Oct 2, 2024
Mcgraw Laurie Director $0 Oct 2, 2024
Margie L. Traylor Director $0 Oct 2, 2024
Paul Ginocchio Chief Financial Officer $0 -$2.8K -100% Oct 2, 2024

Recent Insider Transactions by Companies or Individuals for Augmedix, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.